<DOC>
	<DOCNO>NCT00823966</DOCNO>
	<brief_summary>The objective surveillance collect information 1 ) adverse drug reaction expect Local Product Document ( LPD ) ( unlisted adverse drug reaction ) , 2 ) incidence adverse drug reaction surveillance , 3 ) factor consider affect safety and/or efficacy drug .</brief_summary>
	<brief_title>Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus ( HIV ) Patients</brief_title>
	<detailed_description>All patient investigator prescribes first Rescriptor® register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Delavirdine</mesh_term>
	<criteria>Patients need administer Rescriptor® order enrol surveillance . Patients administer Rescriptor® .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>